Terms: = Liver cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1
18 results:
1. Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome.
Pascut D; Giraudi PJ; Banfi C; Ghilardi S; Tiribelli C; Bondesan A; Caroli D; Minocci A; Grugni G; Sartorio A
Front Endocrinol (Lausanne); 2023; 14():1254778. PubMed ID: 38034016
[TBL] [Abstract] [Full Text] [Related]
2. Upregulated cant1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract] [Full Text] [Related]
3. The role of
Wang G; Zhang W; Luan X; Wang Z; Liu J; Xu X; Zhang J; Xu B; Lu S; Wang R; Ma G
Front Immunol; 2023; 14():1151967. PubMed ID: 37215117
[TBL] [Abstract] [Full Text] [Related]
4. Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology.
Yang C; Huang X; Li Y; Chen J; Lv Y; Dai S
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32789496
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal cancer.
Nemeth Z; Wijker W; Lengyel Z; Hitre E; Borbely K
Pathol Oncol Res; 2020 Oct; 26(4):2683-2691. PubMed ID: 32661836
[TBL] [Abstract] [Full Text] [Related]
6. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
[TBL] [Abstract] [Full Text] [Related]
7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
[TBL] [Abstract] [Full Text] [Related]
8. Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response.
Yan S; Jiang X; Yang J; Yan D; Wang YX
Cancer Biother Radiopharm; 2012 Oct; 27(8):519-23. PubMed ID: 22834655
[TBL] [Abstract] [Full Text] [Related]
9. Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.
Mertens J; Dobbeleir A; Ham H; D'Asseler Y; Goethals I; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1441-8. PubMed ID: 22699529
[TBL] [Abstract] [Full Text] [Related]
10. Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Tsai MC; Wang JH; Hung CH; Kee KM; Yen YH; Lee CM; Hu TH; Chen CH; Lu SN
J Gastroenterol Hepatol; 2010 Mar; 25(3):605-12. PubMed ID: 20074164
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical value of CT-guided high frequency-induced thermotherapy as a treatment for intrahepatic cholangiocarcinoma].
Fan WJ; Zhang L; Gu YK; Wang LG; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(25):1759-62. PubMed ID: 19035087
[TBL] [Abstract] [Full Text] [Related]
12. Cystic lesions in the liver: benign or malignant?
Varin OC; Varin DS; Berrevoet FC
Acta Chir Belg; 2007; 107(5):554-6. PubMed ID: 18074919
[TBL] [Abstract] [Full Text] [Related]
13. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract] [Full Text] [Related]
14. [Assessment of radiation-induced liver injury with computed tomography].
Zhu XX; Chen LH; Wu DH; Chen YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):109-12. PubMed ID: 17259163
[TBL] [Abstract] [Full Text] [Related]
15. Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
Matsuoka M; Boku N; Yoshino T; Hironaka S; Onozawa Y; Fukutomi A; Zenda S; Yamazaki K; Yasui H; Hasuike N; Inui T; Yamaguchi Y; Ono H; Kamata M
Int J Clin Oncol; 2005 Dec; 10(6):429-32. PubMed ID: 16369748
[TBL] [Abstract] [Full Text] [Related]
16. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract] [Full Text] [Related]
17. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
Agrawal M; Abraham J; Balis FM; Edgerly M; Stein WD; Bates S; Fojo T; Chen CC
Clin Cancer Res; 2003 Feb; 9(2):650-6. PubMed ID: 12576431
[TBL] [Abstract] [Full Text] [Related]
18. Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.
Link KH; Aigner KR; Kuehn W; Schwemmle K; Kern DH
Cancer Res; 1986 Sep; 46(9):4837-40. PubMed ID: 3731130
[TBL] [Abstract] [Full Text] [Related]